Stock data
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT) reported revenue of US$175.11M and net income of -US$221.25M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$175.11M | US$152.51M | -US$159.99M | -US$221.25M | — |
| 2024 | US$55.25M | US$47.28M | -US$277.47M | -US$334.33M | — |
| 2023 | US$0.68M | US$0.52M | -US$167.31M | -US$201.59M | — |
| 2022 | US$0.00M | US$0.00M | -US$172.44M | -US$197.72M | — |
| 2021 | — | — | -US$135.08M | -US$143.88M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$74.27M | -US$17.58M | — |
| 2026-03-31 | US$58.30M | -US$30.37M | — |
| 2025-12-31 | US$57.58M | -US$21.15M | — |
| 2025-09-30 | US$49.50M | -US$29.97M | — |
| 2025-06-30 | US$39.50M | -US$75.81M | — |
| 2025-03-31 | US$28.52M | -US$94.32M | — |
| 2024-12-31 | US$29.66M | -US$74.45M | — |
| 2024-09-30 | US$16.35M | -US$85.58M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.